Centauri Therapeutics to present at 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

NEXT STORY
Latin America Cell Culture (Consumables and Instruments) Market Analysis and Forecast 2018-2025
PREV STORY
Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PIH Health Primary Care Physicians Offer an Array of Services to Better Patient Health

Whittier, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PIH Health offers an array of ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Announces the Initiation of a Phase 1b/2 Clinical Trial of CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer

author_avatar
NASDAQ Market News

Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021 Virtual Meeting

author_avatar
NASDAQ Market News